In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
A comprehensive view of the IVD market with test categories covered and company briefs
M&A activities, selected partnerships & collaborations, partnership deals, and more
Industry & region watch to help tailor strategies
Analysis of news and events and reporting on news not easily available
Table of Contents
Volume 3, Issue 1 – Focus on Molecular HLA Testing
Market Analysis: Molecular HLA/Transplant Testing
Overview of Molecular HLA/Transplant Testing
Market Outlook
Regional Market
Top Company Briefs
Immucor
Luminex/DiaSorin
CareDx
Thermo Fisher Scientific
Executive News Briefing
DEKFI Diagnostics Appoint New CEO
Onera Raises $32 Million in Funding
Cleveland Diagnostics Completes $75 Million in Funding
Financial Highlights: Agilent and Hologic
Agilent Full Year Fiscal 2023 Sales up 1.5% in Core Business YOY
Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)
Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States, All Others), FY 2023 (%)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
India
Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)
Saudi Arabia
Figure: Saudi Arabia Population Pyramid, 2023 and 2053
Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023
Broad-based Company Announcements
QuidelOrtho Obtains FDA Nod
Illumina Plans to Divest Grail
Roche to Acquire LumiraDx
QIAGEN Expands Footprint with New Regional Headquarters in Middle East
Volume 3, Issue 2 – Focus on Immunoassay Overview
Market Analysis
Overview of IVD Immunoassay
Market Outlook
Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
Regional Market
Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)
Top Company Briefs
Roche
Abbott Diagnostics
Siemens Healthineers
Other Selected Immunoassay News
Executive News Briefing
NOWDiagnostics Selects New Science Officer
Freenome Raises $254 Million in New Funding
QuidelOrtho Axes CEO
Agilent CEO to Retire
Financial Highlights: Bio-Rad Laboratories and Veracyte
Bio-Rad Laboratories Reports Full-Year 2023 Clinical Diagnostics Revenues up 3.2% over previous year
Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
Figure: Bio-Rad Laboratories’ Sales by Business, 2022 vs. 2023, $M
Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution
Veracyte Reported Strong Performance in 2023
Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
Virus Testing Update
Region Watch
Peru
Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
Figure: Peru GDP Value and Growth by Year, 2010-2022
Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023
South Africa
Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)
Broad-based Company Announcements
Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome
DiaSorin Nabs FDA Clearance for New LIAISON PLEX System
T2 Biosystems Offers Expanded Panel
Cepheid Received FDA Clearance for Xpert Xpress GBS
DiaCarta Collaboration to Launch Prostate Cancer LDT
Volume 3, Issue 3 – Clinical Chemistry
Market Analysis: Clinical Chemistry
Overview of Clinical Chemistry Market
Market Outlook
Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
Major Product Activity
Lab-based Clinical Chemistry
Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
